A post-hoc analysis of intravitreal aflibercept-treated nAMD patients from ARIES & ALTAIR: predicting treatment intervals and frequency for aflibercept treat-and-extend therapy regimen using machine learning

Matthias Gutfleisch, Britta Heimes-Bussmann, Sökmen Aydin, Ratko Petrovic, Alexander Loktyushin, Masahito Ohji, Kanji Takahashi, Annabelle A. Okada, Paula Scholz, Hossam Youssef, Ulrike Bauer-Steinhusen, Tobias Machewitz, Kai Rothaus, Albrecht Lommatzsch

Open source

DOI: 10.1007/s00417-025-06812-x
Published: 2025-04-10
Container: Graefe's Archive for Clinical and Experimental Ophthalmology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00417-025-06812-x,
  title = {A post-hoc analysis of intravitreal aflibercept-treated nAMD patients from ARIES \&amp; ALTAIR: predicting treatment intervals and frequency for aflibercept treat-and-extend therapy regimen using machine learning},
  author = {Matthias Gutfleisch and Britta Heimes-Bussmann and Sökmen Aydin and Ratko Petrovic and Alexander Loktyushin and Masahito Ohji and Kanji Takahashi and Annabelle A. Okada and Paula Scholz and Hossam Youssef and Ulrike Bauer-Steinhusen and Tobias Machewitz and Kai Rothaus and Albrecht Lommatzsch},
  year = {2025},
  journal = {Graefe's Archive for Clinical and Experimental Ophthalmology},
  doi = {10.1007/s00417-025-06812-x},
  url = {https://doi.org/10.1007/s00417-025-06812-x}
}

RIS

TY  - JOUR
TI  - A post-hoc analysis of intravitreal aflibercept-treated nAMD patients from ARIES &amp; ALTAIR: predicting treatment intervals and frequency for aflibercept treat-and-extend therapy regimen using machine learning
AU  - Matthias Gutfleisch
AU  - Britta Heimes-Bussmann
AU  - Sökmen Aydin
AU  - Ratko Petrovic
AU  - Alexander Loktyushin
AU  - Masahito Ohji
AU  - Kanji Takahashi
AU  - Annabelle A. Okada
AU  - Paula Scholz
AU  - Hossam Youssef
AU  - Ulrike Bauer-Steinhusen
AU  - Tobias Machewitz
AU  - Kai Rothaus
AU  - Albrecht Lommatzsch
PY  - 2025
JO  - Graefe's Archive for Clinical and Experimental Ophthalmology
DO  - 10.1007/s00417-025-06812-x
UR  - https://doi.org/10.1007/s00417-025-06812-x
ER  -

APA

Gutfleisch, M., Heimes-Bussmann, B., Aydin, S., Petrovic, R., Loktyushin, A., Ohji, M., Takahashi, K., Okada, A. A., Scholz, P., Youssef, H., Bauer-Steinhusen, U., Machewitz, T., Rothaus, K., & Lommatzsch, A. (2025). A post-hoc analysis of intravitreal aflibercept-treated nAMD patients from ARIES & ALTAIR: predicting treatment intervals and frequency for aflibercept treat-and-extend therapy regimen using machine learning. Graefe's Archive for Clinical and Experimental Ophthalmology. https://doi.org/10.1007/s00417-025-06812-x

Source records

crossref · retrieved 2026-09-26T05:46:29.471Z

A post-hoc analysis of intravitreal aflibercept-treated nAMD patients from ARIES &amp; ALTAIR: predicting treatment intervals and frequency for aflibercept treat-and-extend therapy regimen using machine learning

Credibility signals

Cite this work

BibTeX

RIS

APA

Source records

A post-hoc analysis of intravitreal aflibercept-treated nAMD patients from ARIES & ALTAIR: predicting treatment intervals and frequency for aflibercept treat-and-extend therapy regimen using machine learning